Suchergebnisse - "Guan, Z.-Z."

PubPharm (48)

1

Transcriptomic analysis of the ΔPaLoc mutant of Clostridioides difficile and verification of its toxicity

enthalten in: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine | 2022

von Cui, G. | Zhou, Q. | Cheng, Q. | +10

2

Fluoride induced down-regulation of IKBKG Gene expression inhibits hepatocytes senescence

enthalten in: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) | 2022

von Wu, C. | Mao, C. | Deng, J. | +5

3

Antagonism of lovastatin on oxidative stress and apoptosis in primary rat hippocampal neurons induced by β-amyloid peptide

enthalten in: Zhonghua bing li xue za zhi = Chinese journal of pathology | 2017

von Tan, L. | Zhao, L. | Liu, X. | +2

4

Study on association between HLA-DP gene polymorphism and susceptibility to hepatitis B virus infection in minority population in Guizhou province

enthalten in: Zhong hua liu xing bing xue za zhi | 2016

von Zhao, X. | He, Y. | Zhang, T. | +4

5

Multifocal central nervous system hemangioblastoma : a case report and review of the literature

enthalten in: Genetics and molecular research : GMR | 2014

von Chu, L. | Guan, Z. | Liu, J. | +6

6

PD-0001 * CETUXIMAB EVERY 2 WEEKS WITH FIRST-LINE CHEMOTHERAPY IN APEC STUDY PATIENTS WITH METASTATIC COLORECTAL CANCER GROUPED ACCORDING TO EGFR EXPRESSION

enthalten in: Annals of oncology | 2014

von Cheng, A. | Cornelio, G. | Shen, L. | +16

7

Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC : data of subgroup analyses from MO19390 (SAiL) study

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2014

von Zhou, C. | Bai, C. | Guan, Z. | +6

8

Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study

enthalten in: Clinical & translational oncology | 2014

von Zhou, C. | Bai, C. | Guan, Z. | +6

9

Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study

enthalten in: Revista de oncología | 2013

von Zhou, C. | Bai, C. | Guan, Z. | +6

10

Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors

enthalten in: Cancer gene therapy | 2009

von Xu, F. | Li, S. | Li, X. | +8

1
2
3
4
5
Nächster »
[5]